atovaquone
Generic: atovaquone
Labeler: chartwell governmental & specialty rx, llc.Drug Facts
Product Profile
Brand Name
atovaquone
Generic Name
atovaquone
Labeler
chartwell governmental & specialty rx, llc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
atovaquone 750 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
68999-528
Product ID
68999-528_430808cb-6a2f-94ee-e063-6394a90ab6fd
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207833
Listing Expiration
2026-12-31
Marketing Start
2017-04-28
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68999528
Hyphenated Format
68999-528
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
atovaquone (source: ndc)
Generic Name
atovaquone (source: ndc)
Application Number
ANDA207833 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 750 mg/5mL
Packaging
- 2 TRAY in 1 BOX (68999-528-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-528-45)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "430808cb-6a2f-94ee-e063-6394a90ab6fd", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["e6770b85-54f8-4969-af02-7d81586be761"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["Chartwell Governmental & Specialty RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (68999-528-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-528-45)", "package_ndc": "68999-528-24", "marketing_start_date": "20251025"}], "brand_name": "Atovaquone", "product_id": "68999-528_430808cb-6a2f-94ee-e063-6394a90ab6fd", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "68999-528", "generic_name": "Atovaquone", "labeler_name": "Chartwell Governmental & Specialty RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA207833", "marketing_category": "ANDA", "marketing_start_date": "20170428", "listing_expiration_date": "20261231"}